Ms. Spivack serves as Non-Executive Chairwoman of Excelin Health, a Corinthian portfolio company. She joined the company’s board in 2018 and was named chairwoman in 2022.

As executive advisor to Corinthian, she provides valuable insight and expertise for sourcing opportunities and evaluating acquisitions in the healthcare industry.

Ms. Spivack has spent her professional life focused on advising corporate executives and boards on the execution of strategic and financial transactions for publicly-traded, privately-held and not-for-profit healthcare services companies, globally. Her passion for healthcare began early in her career, as a practicing medical surgical nurse and continued throughout a 30-year career in mergers and acquisitions. She brings strategic thinking and insight, a deep understanding of business operations, and strong financial acumen developed over a career of creating stakeholder value, to the boardroom. She currently sits on the Boards of several post-acute healthcare companies in addition to serving as the Past Chairperson of the Board of Community Health Accreditation Partner (CHAP) the national accreditation body for community-based healthcare.

During her investment banking career, Ms. Spivack served as Managing Director and Co-Head of KPMG Healthcare Corporate Finance, Managing Director Investment Banking, Morgan Keegan, Managing Director Global Healthcare Investment Banking Group, UBS, Managing Director and Head of the Healthcare Strategic Advisory Group, Merrill Lynch, and was a Partner and Head of the National Health Care Corporate Finance Practice at Ernst & Young.

Ms. Spivack received a B.S. in Nursing from State University of New York in Albany, an M.S. in Health Planning from the University of Pennsylvania and an M.B.A. from The Wharton School, University of Pennsylvania.